Global Flow Cytometry News
Read article KCAS Bio Advances Global Flow Cytometry with AI-Driven Efficiency and Harmonized Delivery

In modern bioanalytical research, data quality remains the defining metric of success. At the same time, study complexity continues to increase. KCAS Bio is advancing its global flow cytometry services with a focused strategy that integrates AI-enabled efficiencies, harmonized workflows, and high-parameter technologies. The goal is…

KCAS-podcast-thumb_TCF-030 Podcasts
Listen to podcast Podcast (The Conversational Flow) Eps #30: ”Automation: Flow Cytometry on Cruise Control”

The main discussion of this 30th episode of “The Conversational Flow” centers on automation in flow cytometry, focusing on a recent paper comparing three major sample preparation systems and their impact on efficiency, standardization, and error reduction. Our hosts, Adam and Brian, explore how automation can significantly reduce hands-on time…

KCAS-blog-thumb_2026-02-RO Assay and TE Blogs
Read article From Preclinical to Clinical: Tracking Target Binding in Solid Tumor Therapy

At KCAS Bio, we supported a therapeutic monoclonal antibody for advanced solid tumors from non-human primate (NHP) toxicology through first-in-human (FIH) dose escalation into phase 2 expansion. This project combined receptor occupancy assays (ROA) by flow cytometry for cell-surface binding on monocytes, immunophenotyping (IPT) for activation markers, and…

Continuous Flow Cytometry for CAR-T PK/PD from Phase I to Global Trials Blogs
Read article Continuous PK/PD Flow Cytometry Support for CAR-T Cell Therapy, from Phase I to Global Expansion

Evolving CAR Therapies and the Growing Need for Robust PK/PD Monitoring Chimeric Antigen Receptor (CAR) based therapies are a growing and continuing focus in oncology and autoimmune therapeutic development. They utilize either self (autologous) or donor-derived (allogenic) T cells that are genetically engineered to target and kill cancerous or autoreactive…

KCAS-podcast-thumb_TCF-029 Podcasts
Listen to podcast Podcast (The Conversational Flow) Eps #29: ”Accelerating Cancer Immunotherapy: Insights from ACIR”

In episode #29 of “The Conversational Flow” podcast, our hosts, Brian and Adam, are joined by guests from Accelerating Cancer Immunotherapy Research (ACIR), a nonprofit dedicated to sharing important advances in cancer immunotherapy with the scientific community and the public. Ute Burkhardt discusses her background in cancer vaccines and neoantigen-driven…

Cross-Site Validation of A 15-Color Spectral Cytometry Panel for Leukocyte Profiling Blogs
Read article Cross-Site Validation of a 15-Color Spectral Cytometry Panel for Leukocyte Profiling

Reliable immune profiling across global studies depends on methods that perform consistently, regardless of where they are run. We address this question in the white paper entitled “Cross-Site Validation of a 15-Color Spectral Cytometry Panel for Leukocyte Profiling,” documenting a global collaboration between KCAS Bio and its strategic partner,…

GlobalHarmonization_KCASBio Posters & Papers
Read article Cross-Site Validation of a 15-Color Spectral Cytometry Panel for Leukocyte Profiling

Discover in this white paper a global collaboration between KCAS Bio and its strategic partner, Crux Biolabs, to harmonize and validate a standardized 15-color spectral flow cytometry panel for pan-leukocyte profiling across multiple sites. If you have any questions about these services or any others offered by…

KCAS-podcast-thumb_TCF-028 Podcasts
Listen to podcast Podcast (The Conversational Flow) Eps #28: ”Why Standardization Is Critical in Immunophenotyping”

In episode 28 of “The Conversational Flow”, our hosts, Adam and Brian, discuss why standardization is essential for credible flow cytometry data at scale. They walk through the biggest sources of variability – reagents and lots, sample handling and shipping time, anticoagulants and processing choices (whole blood vs. PBMCs, fresh…

CellStimulation_KCASBio Blogs
Read article Cell Stimulation for Flow Cytometry

Why Cell Stimulation Matters in Flow Cytometry Many flow cytometry users are happy to start an experiment with a general protocol and a question about their specimen: Will my cells make more cytokines or express more markers after activation? In a healthy person, immune cells like B cells, T cells,…

KCAS-podcast-thumb_TCF-027 Podcasts
Listen to podcast Podcast (The Conversational Flow) Eps #27: ”Tis the Season for Holiday Lights and Flow Cytometry”

This pre-holiday episode of “The Conversational Flow” dives into how scientific understanding evolves over time, using immunology as a case study to highlight how often researchers underestimate what they don’t yet know. Adam and Brian reflect on historical quotes from medicine and science that confidently declared fields “complete,” only to…

Leveraging Flow Cytometry to Analyze Pharmacodynamic and Persistence Endpoints in Cell Therapy Clinical Trials Blogs
Read article Leveraging Flow Cytometry to Analyze Pharmacodynamic and Persistence Endpoints in Cell Therapy Clinical Trials

Cell therapy clinical trials present unique challenges when it comes to monitoring both pharmacodynamic (PD) and persistence endpoints. Unlike traditional small molecules or biologics, cell therapies involve living products that interact dynamically with the patient’s immune system. Understanding how these cells persist, expand, and function in vivo is critical for…

The Backbone Advantage: Smarter Flow Cytometry for Translational and Clinical Research Blogs
Read article The Backbone Advantage: Smarter Flow Cytometry for Translational and Clinical Research

For flow cytometry methods, reproducibility and scalability are crucial as programs move from discovery to the clinic. When it comes to maintaining consistent flow cytometry data over time, across different collection sites, or across multiple clinical studies, there are important challenges to consider. Backbone flow cytometry panels – well-characterized, optimized,…